The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the withdrawal, suspension, or cancellation of 101 pharmaceutical products in Nigeria, effective immediately. These products are no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale, and use within the country.
Reasons for Withdrawal:
– Licensing issues
– Voluntary withdrawal by market authorization holders
– Failure to meet registration requirements
Examples of Withdrawn Products:
– Antimalarials:
– Artemether/Lumefantrine 40mg/240mg Tablets
– ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets
– ASAQ (Artesunate Amodiaquine Winthrop) 25mg/67.5mg Tablets
– Diabetes Medicines:
– Januvia 100mg Tablets
– Janumet 50mg/1000mg Tablets
– Kombiglyze 2.5mg/1000mg Tablets
– Cardiovascular Drugs:
– Aprovasc 150mg/5mg Tablets
– Coaprovel 300mg/25mg Tablets
– Triveram 10mg/5mg/5mg Tablets
– Other Products:
– Invanz 1g Injections
– Invega (Paliperidone) 3mg Extended Release Tablets
– Flagyl Suspension and Tablets
Action Required:
NAFDAC advises the public to discontinue the use, sale, and distribution of these products to ensure safety and compliance. The list of withdrawn, suspended, and canceled products is available on the NAFDAC website.
